Feng Jianhua, Wu Caixiu, Shen Fei, Cai Wensong, Xu Bo
Department of General Surgery, The First Affiliated Hospital, Jinan University, Guangzhou, Guangdong 510630, P.R. China.
Department of Thyroid Surgery, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou 510180, P.R. China.
J Clin Endocrinol Metab. 2025 Jan 21;110(2):417-428. doi: 10.1210/clinem/dgae501.
Adult cancer survivors are at a heightened risk for secondary primary differentiated thyroid carcinoma (2-DTC). The characteristics and outcomes of 2-DTC remain poorly understood.
We aimed to explore the characteristics and outcomes of 2-DTC.
We retrospectively analyzed data from the Surveillance, Epidemiology, and End Results (SEER) database (2000-2017). 2-DTC was divided into 25 subgroups based on prior primary malignancies (PPMs). Baseline characteristics were compared using the chi-square test. Multivariable logistic analysis was used to identified if PPMs were associated with aggressive DTC characteristics. DTC-specific and cancer-specific mortality were analyzed using a univariable and multivariable competing risk regression model.
There were 138 555 1-DTC and 9253 2-DTC patients identified. 2-DTC patients were predominantly older, male, and White compared to first primary DTC (1-DTC) (all P < .05). In multivariable logistic regression analysis, only 4 types of PPMs were associated with higher rates of DTC aggressive characteristics, while 19 types exhibited lower rates (all P < .05). In multivariable competing risk analysis, 2-DTC showed no mortality risk in stages I (SHR: 1.16; 95% CI, 0.65-2.07) and II (SHR: 0.67; 95% CI, 0.45-1.01), but a protective role in stages III (SHR: 0.47; 95% CI, 0.27-0.83) and IV (SHR: 0.72; 95% CI, 0.52-0.99). Most PPMs that developed into 2-DTC had a lower risk of DTC-specific death than 1-DTC, but many PPMs had a higher risk of cancer-specific death.
Given the characteristics and outcomes of 2-DTC, aggressive treatment for 2-DTC, particularly for PPM with a high mortality risk, may not be advisable.
成年癌症幸存者患继发性原发性分化型甲状腺癌(2-DTC)的风险更高。2-DTC的特征和预后仍知之甚少。
我们旨在探讨2-DTC的特征和预后。
我们回顾性分析了监测、流行病学和最终结果(SEER)数据库(2000 - 2017年)中的数据。根据既往原发性恶性肿瘤(PPM)将2-DTC分为25个亚组。使用卡方检验比较基线特征。多变量逻辑分析用于确定PPM是否与侵袭性DTC特征相关。使用单变量和多变量竞争风险回归模型分析DTC特异性和癌症特异性死亡率。
共识别出138555例原发性DTC(1-DTC)患者和9253例2-DTC患者。与原发性DTC(1-DTC)相比,2-DTC患者主要为年龄较大、男性和白人(所有P <.05)。在多变量逻辑回归分析中,只有4种类型的PPM与较高的DTC侵袭性特征发生率相关,而19种类型的发生率较低(所有P <.05)。在多变量竞争风险分析中,2-DTC在I期(SHR:1.16;95% CI,0.65 - 2.07)和II期(SHR:0.67;95% CI,0.45 - 1.01)没有死亡风险,但在III期(SHR:0.47;95% CI,0.27 - 0.83)和IV期(SHR:0.72;95% CI,0.52 - 0.99)具有保护作用。大多数发展为2-DTC的PPM的DTC特异性死亡风险低于1-DTC,但许多PPM的癌症特异性死亡风险较高。
鉴于2-DTC的特征和预后,对2-DTC进行积极治疗,特别是对具有高死亡风险的PPM,可能并不可取。